Full Text View
Tabular View
No Study Results Posted
Related Studies
Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency
This study has been terminated.
( study was stopped after enrolment of about 200 patients for slow recruitment )
Study NCT00927602   Information provided by Università degli Studi dell'Insubria

First Received on June 24, 2009.   Last Updated on April 23, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Medical Patients
Renal Insufficiency
Additional conditions recognized in this trial
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Kidney Diseases
Thrombosis
Urologic Diseases
Vascular Diseases
Interventions listed in this trial
fondaparinux
Additional drug interventions recognized in this trial
PENTA
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Università degli Studi dell'Insubria


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services